Labiotech.eu

In Depth 9 Oct 2023

The biggest private biotech investments in September 2023

The companies Generate Biomedicines, Apollo Therapeutics and Nimbus Therapeutics bagged the biggest biotech investments in September 2023. Around the world, drug discovery and oncology players attracted the biggest funding rounds. As we made our way into autumn in the Northern Hemisphere, September 2023 saw some big funding rounds take place around the globe, particularly within […]

October 9, 2023 - 3 minutesmins - By Willow Shah-Neville

In Depth 6 Oct 2023

Will the U.S. Cancer Moonshot program land its target to halve cancer death rates?

It was predicted that more than 600,000 people would die from cancer last year in the U.S., according to the American Cancer Society. But what if those figures could be halved over the next couple of decades? Although no small feat, that’s precisely what the Cancer Moonshot program aims to do. The White House initiative, […]

October 6, 2023 - 10 minutesmins - By Roohi Mariam Peter

Podcast 6 Oct 2023

Beyond Biotech podcast 66 – treating rare diseases with tRNA

Compared to the smallest mRNA molecule, which is 300 nucleotides long, the largest transfer RNAs (tRNA) is less than a third of the size at 76 nucleotides. Scientists at Alltrna are harnessing the unique biology of tRNAs to engineer a single tRNA medicine that could treat thousands of rare diseases that share the same genetic […]

October 6, 2023

In Depth 5 Oct 2023

Saving lives with xenotransplantation: how biotechs are solving the transplant shortage crisis

On January 7, 2022, a surgery was performed on David Bennett to give him a new heart. But this was no ordinary transplant surgery. Instead of receiving a heart from a human donor, the 57-year-old, who did not qualify for a traditional transplant, received a pig heart. This surgery marked a historic breakthrough, becoming the […]

October 5, 2023 - 11 minutesmins - By Willow Shah-Neville

In Depth 4 Oct 2023

CAR-NK: Can natural killer cell therapy pick up from where CAR-T left off?

Riding on the success of CAR-T cell therapy, a breakthrough in the treatment of blood cancers, CAR-NK therapies are an emerging field in therapeutic research that aim to boost an even stronger immune response against cancer. What is CAR-NK cell therapy? Natural killer (NK) cells, like T cells, are white blood cells that are a […]

October 4, 2023 - 7 minutesmins - By Roohi Mariam Peter

Best in Biotech 3 Oct 2023

Five impactful biotech companies to know in New York

New York – the place where people of all backgrounds come with hopes and dreams of making a better life for themselves – is just recently becoming a life sciences powerhouse, attracting many biotech companies, after a $1 billion public investment in the industry from the City of New York. This initiative, called LifeSci NYC, […]

October 3, 2023 - 8 minutesmins - By Willow Shah-Neville

In Depth 2 Oct 2023

PIPEs in biotech fundraising: is this growing trend fueled by economic uncertainty here to stay?

This past year has not been very sympathetic to fundraisers in the biotech industry. As the economic downturn grinds on, many companies are in need of funds to stay afloat. A recent trend in the way biotechs have secured funding, might be telling of how these companies are determined to pull through. A private investment […]

October 2, 2023 - 7 minutesmins - By Roohi Mariam Peter

In Depth 29 Sep 2023

Illumina: DNA giant in troubled waters

A botched acquisition deal and unrest among company investors amid plummeting stocks have plagued Illumina, which was once part of the biotech big leagues that dominated the field of gene sequencing. Now, in fear of losing its ground to other players in the space, it has received a European Commission order to divest Grail, and […]

September 29, 2023 - 8 minutesmins - By Roohi Mariam Peter

Podcast 29 Sep 2023

Beyond Biotech podcast 65 – Disease X and pandemic preparedness

Disease X, a concept shrouded in mystery, represents the unknown pathogens that could unleash future epidemics or pandemics. In the wake of recent global health crises, our understanding of the profound impact of those pandemics has deepened. On this week’s podcast, we have a conversation with Hamilton Bennett, who led Moderna’s mRNA-1273 COVID-19 vaccine development […]

September 29, 2023

In Depth 28 Sep 2023

Obesity drug success sparks biotech buying spree

The last few months have seen the obesity drug market soar, after new weight loss and diabetes drugs like Novo Nordisk’s Wegovy and Ozempic took the world by storm with their incredible efficacy at inducing weight loss. These new drugs belong to a class of medications called GLP-1 analogs (or incretin-based therapies), which work by […]

September 28, 2023 - 7 minutesmins - By Willow Shah-Neville

Skilled labor shortage biopharma manufacturing

Opinion 27 Sep 2023

Tackling the skilled labor shortage in biopharma manufacturing

By Brandy Bullen, founder & CEO of Sequoia Consulting Group The biopharma manufacturing sector stands at a critical juncture as it grapples with an increasingly pronounced skilled labor shortage. In an era marked by rapid advancements in biotechnology and the growing demand for innovative therapies, the industry finds itself facing a pressing challenge – the […]

September 27, 2023 - 6 minutesmins - By External Contributor

In Depth 25 Sep 2023

Base editing hits the clinic in the U.S.

Over the past couple of years, base editing, a recent offshoot of the heralded CRISPR/Cas 9 technology, has been doing its rounds in the biotech space. Now, base editing has finally set foot into clinical trials for the first time in the U.S.. American precision medicine company Beam Therapeutics treated its first patient with its […]

September 25, 2023 - 7 minutesmins - By Roohi Mariam Peter

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The biggest private biotech investments in September 2023

Will the U.S. Cancer Moonshot program land its target to halve cancer death rates?

Beyond Biotech podcast 66 – treating rare diseases with tRNA

Saving lives with xenotransplantation: how biotechs are solving the transplant shortage crisis

CAR-NK: Can natural killer cell therapy pick up from where CAR-T left off?

Five impactful biotech companies to know in New York

PIPEs in biotech fundraising: is this growing trend fueled by economic uncertainty here to stay?

Illumina: DNA giant in troubled waters

Beyond Biotech podcast 65 – Disease X and pandemic preparedness

Obesity drug success sparks biotech buying spree

Tackling the skilled labor shortage in biopharma manufacturing

Base editing hits the clinic in the U.S.

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!